In the rapidly evolving landscape of pharmaceutical research and development, the availability of high-quality chemical intermediates is paramount. One such compound that has garnered significant attention is 3-Cyano-4-isopropoxybenzoic Acid, identified by CAS number 258273-31-3. This molecule, with its distinct cyano and isopropoxy substituents on a benzoic acid core, serves as a linchpin in the synthesis of numerous vital pharmaceutical agents. At NINGBO INNO PHARMCHEM CO.,LTD., we recognize the indispensable nature of such compounds and are dedicated to their meticulous production.

The journey of 3-Cyano-4-isopropoxybenzoic Acid from laboratory synthesis to its application in life-saving drugs is a testament to modern organic chemistry. Its preparation often involves a series of carefully controlled reactions, including the introduction of the isopropoxy group via etherification and the cyano group through specialized chemical transformations. The precision required in these 3-cyano-4-isopropoxybenzoic acid synthesis pathways ensures the purity and efficacy of the final pharmaceutical products. Understanding these CAS 258273-31-3 chemical properties is key for chemists aiming for high yields and minimal by-products.

The significance of this compound is perhaps best illustrated by its use as a key intermediate in the synthesis of drugs like Ozanimod and Dyclonine Hydrochloride. Ozanimod, a sphingosine-1-phosphate (S1P) receptor modulator, is used to treat relapsing forms of multiple sclerosis. The intricate structure of Ozanimod relies heavily on precursors like 3-Cyano-4-isopropoxybenzoic Acid for its successful assembly. Similarly, Dyclonine Hydrochloride, a local anesthetic, benefits from the chemical scaffolding provided by this versatile intermediate. The efficient ozanimod intermediate synthesis heavily depends on reliable suppliers, making NINGBO INNO PHARMCHEM CO.,LTD. a vital partner.

Beyond its role as a synthetic building block, 3-Cyano-4-isopropoxybenzoic Acid exhibits intrinsic biological activities. It is known to act as a non-purine-selective xanthine oxidase inhibitor. Xanthine oxidase is an enzyme crucial in purine metabolism, and its inhibition is a well-established strategy for managing conditions characterized by high uric acid levels, such as gout. This inherent bioactivity further enhances its value in drug discovery, potentially leading to novel therapeutic agents or serving as a starting point for designing more potent enzyme inhibitors. Research into its function as a sphingosine phosphate receptor modulator also points towards its utility in developing treatments for inflammatory and autoimmune diseases.

At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to advancing pharmaceutical innovation by providing the highest quality chemical intermediates. Our expertise in fine chemical synthesis ensures that compounds like 3-Cyano-4-isopropoxybenzoic Acid meet the stringent demands of the pharmaceutical industry. By focusing on quality, reliability, and cutting-edge synthesis techniques, we empower researchers and manufacturers to develop the next generation of life-changing medicines. Explore how our intermediates can accelerate your drug discovery programs.